Searched for
STRIDES PHARMA CONSOLIDATED REVENUE
Accenture cuts revenue outlook, stock crashes 17%Accenture has lowered its annual revenue growth forecast. Companies are still cautious about spending on technology. This is happening even...- Christy Mathai used market dip to buy insurance, logistics stocks; here's his sector-by-sector playbookFund Manager Christy Mathai sees easing war-driven inflation fears, expecting a shorter earnings hit. He's selectively adding to his portfo...
- Italian digital service company Engineering sells two units to AccentureEngineering, a prominent player in Italy's digital services landscape, is parting ways with its Alfahealth and Industries eXcellence units,...
- Tata Motors PV shares plunge 10% after weaker than expected JLR FY27 guidanceTata Motors Passenger Vehicles shares dropped significantly. This followed Jaguar Land Rover's investor day where its financial outlook for...
- Tamil Nadu's excise revenue lags behind Karnataka, Maharashtra: GovtTamil Nadu's excise duty collections significantly lag behind Karnataka and Maharashtra, showing the lowest absolute collection and slowest...
- Stocks in news: Prime Focus, Groww, GIC RE, Wipro, NykaaIndian benchmark indices traded with a positive bias, with the Nifty consolidating near the 24,000 mark and closing near its day's high. Se...
- Govt fundraising drive hits high gearThe government's push for non-tax revenue is off to a strong start, with public asset monetisation nearing 30% of last fiscal year's total ...
- JLR pivots to flexible powertrains amid slow pace of electrificationJaguar Land Rover is adjusting its strategy. The company will offer a mix of petrol, hybrid, and electric vehicles. This change comes after...
- Tata Motors flags 'challenging & volatile' outlook for Jaguar Land RoverTata Motors Passenger Vehicles Limited saw record domestic sales in FY26. However, Jaguar Land Rover faced challenges impacting overall per...
- Sebi drops proceedings against Prime Focus in misleading financials caseSebi has closed adjudication proceedings against Prime Focus and its directors, ruling that the company correctly accounted for business tr...
- UP, Gujarat, Jharkhand, 10 other states record revenue surplus in FY25: CAG reportFifteen Indian states faced revenue deficits in the fiscal year 2024-25. Thirteen states, however, reported revenue surpluses. The Comptrol...
- Army, Airtel join hands for mobile connectivity in Arunachal Pradesh districtThe Indian Army and Bharti Airtel have joined forces to improve mobile network coverage in remote West Kameng district of Arunachal Pradesh...
- Rajesh Exports shares jump 5% after 30% crash in 7 days. How the alleged Rs 15.15 lakh cr fraud saga unfoldedRajesh Exports shares hit the upper circuit after a steep seven-session decline triggered by SEBI’s interim order alleging large-scale reve...
- Quant Small Cap Fund raises stake in Adani Enterprises and 8 others, trims in Aurobindo Pharma and 4 moreQuant Small Cap Fund increased exposure to Adani Enterprises and eight other stocks in May while reducing holdings in Aurobindo Pharma and ...
- Two Trades for Today: 2 pharma companies – a large-cap for a 5% rise, and a mid-cap stock for a gain of 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Market Trading Guide: Allied Blenders among 2 stock recommendations for FridayDomestic markets recovered modestly on easing oil prices and selective buying in banking and pharma stocks. Analysts have recommended Allie...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Adani Energy Solutions’ IntelliSmart deal seen a costly but timely betIn a bold strategic move, Adani Energy Solutions has secured the smart metering firm IntelliSmart Infrastructure for a staggering ₹3,050 cr...
- Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, VedantaIndian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
Load More
